These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 1670699)

  • 1. Endothelin, vasoconstriction, and endothelial damage in Raynaud's phenomenon.
    Cimminiello C; Milani M; Uberti T; Arpaia G; Perolini S; Bonfardeci G
    Lancet; 1991 Jan; 337(8733):114-5. PubMed ID: 1670699
    [No Abstract]   [Full Text] [Related]  

  • 2. [Serum endothelin in patients with Raynaud syndrome before and following cold provocation].
    von Bierbrauer A; Herzog U; Ehlenz K; Wichert P
    Vasa Suppl; 1991; 33():156-7. PubMed ID: 1788654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of total-body cold exposure on plasma concentrations of von Willebrand factor, endothelin-1 and thrombomodulin in systemic lupus erythematosus patients with or without Raynaud's phenomenon.
    Matsuda J; Tsukamoto M; Gohchi K; Saitoh N; Miyajima Y; Kazama M
    Acta Haematol; 1992; 88(4):189-93. PubMed ID: 1337960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Endothelin-1 in pathogenesis of Raynaud's syndrome].
    Knapik-Kordecka M; Adamiec R; Ciosek W
    Pol Merkur Lekarski; 2001 Jun; 10(60):424-5. PubMed ID: 11503255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pathogenic role for endothelin in Raynaud's phenomenon?
    Bottomley W; Goodfield M
    Acta Derm Venereol; 1994 Nov; 74(6):433-4. PubMed ID: 7701873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum endothelin-1 concentrations and cold provocation in primary Raynaud's phenomenon.
    Zamora MR; O'Brien RF; Rutherford RB; Weil JV
    Lancet; 1990 Nov; 336(8724):1144-7. PubMed ID: 1978025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measurement of soluble adhesion molecules in primary Raynaud's phenomenon and in Raynaud's phenomenon secondary to connective tissue diseases.
    Brevetti G; De Caterina M; Martone VD; Corrado S; Silvestro A; Spadaro G; Scopacasa F
    Int J Clin Lab Res; 2000; 30(2):75-81. PubMed ID: 11043500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased factor VIII/von Willebrand factor antigen and von Willebrand factor activity in scleroderma and in Raynaud's phenomenon.
    Kahaleh MB; Osborn I; LeRoy EC
    Ann Intern Med; 1981 Apr; 94(4 pt 1):482-4. PubMed ID: 6782927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistent Raynaud's phenomenon after exposure to vinyl chloride monomer: assessment of endothelial damage.
    Fontana L; Marion MJ; Catilina P
    Clin Exp Rheumatol; 2004; 22(1):132-3. PubMed ID: 15005018
    [No Abstract]   [Full Text] [Related]  

  • 10. Endothelin and Raynaud's phenomenon.
    Kanno K; Hirata Y; Emori T; Ohta K; Shichiri M; Shinohara S; Chida Y; Tomura S; Marumo F
    Am J Med; 1991 Jan; 90(1):130-2. PubMed ID: 1986582
    [No Abstract]   [Full Text] [Related]  

  • 11. [The effect of beraprost sodium on the Raynaud's phenomenon].
    Hiida M; Ushiyama O; Suzuki N; Ohta A; Nagasawa K; Yamaguchi M
    Nihon Rinsho Meneki Gakkai Kaishi; 1996 Jun; 19(3):193-200. PubMed ID: 8810544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma endothelin correlates with antiendothelial antibodies in patients with mixed connective tissue disease.
    Filep JG; Bodolay E; Sipka S; Gyimesi E; Csipö I; Szegedi G
    Circulation; 1995 Nov; 92(10):2969-74. PubMed ID: 7586267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased plasma endothelin levels in patients with Raynaud's phenomenon.
    Biondi ML; Marasini B; Bassani C; Agastoni A
    N Engl J Med; 1991 Apr; 324(16):1139-40. PubMed ID: 2008192
    [No Abstract]   [Full Text] [Related]  

  • 14. Endothelin-1 in patients with Raynaud's phenomenon.
    Smits P; Hofman H; Rosmalen F; Wollersheim H; Thien T
    Lancet; 1991 Jan; 337(8735):236. PubMed ID: 1670862
    [No Abstract]   [Full Text] [Related]  

  • 15. [Plasma endothelin concentration during cold provocation in primary Raynaud's syndrome].
    von Bierbrauer A; Ehlenz K; Herzog P; Cassel W; von Wichert P
    Dtsch Med Wochenschr; 1995 Jun; 120(25-26):902-6. PubMed ID: 7600925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. von Willebrand factor activity in primary and in scleroderma-associated Raynaud's phenomenon.
    Cuenca R; Fernadez-Cortijo J; Fonollosa V; Lima J; Simeon CP; Vilardell M; Pico M
    Lancet; 1990 May; 335(8697):1095. PubMed ID: 1970389
    [No Abstract]   [Full Text] [Related]  

  • 17. Mechanisms of Raynaud's disease.
    Cooke JP; Marshall JM
    Vasc Med; 2005 Nov; 10(4):293-307. PubMed ID: 16444858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Raynaud's phenomenon, calcitonin gene-related peptide, endothelin, and cutaneous vasculature.
    Dowd PM; Bunker CB; Bull HA; Foreman JC; Terenghi G; Springall DR; Polak JM
    Lancet; 1990 Oct; 336(8721):1014. PubMed ID: 1976998
    [No Abstract]   [Full Text] [Related]  

  • 19. Plasma levels of tissue-type plasminogen activator and von Willebrand factor in patients with Raynaud's phenomenon.
    Marasini B; Cugno M; Agostoni A
    Arthritis Rheum; 1991 Feb; 34(2):255-6. PubMed ID: 1899793
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of isradipine on endothelin-1 plasma concentrations in patients with Raynaud's phenomenon.
    La Civita L; Giuggioli D; Del Chicca MG; Longombardo G; Pasero G; Ferri C
    Ann Rheum Dis; 1996 May; 55(5):331-2. PubMed ID: 8660111
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.